| http://dbpedia.org/ontology/abstract
|
Juno Therapeutics Inc is an American bioph … Juno Therapeutics Inc is an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO. On January 22, 2018, Juno Therapeutics was acquired by biotechnology company Celgene for $9 billion. In November 2019, Bristol-Myers Squibb (BMS) announced that it has completed its acquisition of Celgene. has completed its acquisition of Celgene.
|
| http://dbpedia.org/ontology/foundingYear
|
2013
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/CFO +
, http://dbpedia.org/resource/Chief_science_officer +
, http://dbpedia.org/resource/Chief_Medical_Officer +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Seattle +
|
| http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/Bristol-Myers_Squibb +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Juno_Therapeutics_logo.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.bms.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
47030169
|
| http://dbpedia.org/ontology/wikiPageLength
|
9277
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122468143
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Health_care_companies_based_in_Washington_%28state%29 +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Chief_science_officer +
, http://dbpedia.org/resource/IPO +
, http://dbpedia.org/resource/Chimeric_antigen_receptor_T_cell +
, http://dbpedia.org/resource/Chimeric_antigen_receptor +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/Merck_KGaA +
, http://dbpedia.org/resource/Chief_Medical_Officer +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Category:2013_establishments_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Seattle_Children%27s_Research_Institute +
, http://dbpedia.org/resource/Celgene +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2013 +
, http://dbpedia.org/resource/Fred_Hutchinson_Cancer_Research_Center +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Companies_based_in_Seattle +
, http://dbpedia.org/resource/Seattle +
, http://dbpedia.org/resource/Editas_Medicine +
, http://dbpedia.org/resource/MedImmune +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/B-cell_lymphoma +
, http://dbpedia.org/resource/CFO +
, http://dbpedia.org/resource/Lisocabtagene_maraleucel +
, http://dbpedia.org/resource/Category:2018_mergers_and_acquisitions +
, http://dbpedia.org/resource/Memorial_Sloan_Kettering_Cancer_Center +
, http://dbpedia.org/resource/Memorial_Sloan-Kettering_Cancer_Center +
, http://dbpedia.org/resource/Gene_therapy +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/AstraZeneca +
, http://dbpedia.org/resource/Immunotherapy +
|
| http://dbpedia.org/property/foundation
|
2013
|
| http://dbpedia.org/property/homepage
|
https://www.bms.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Hans Bishop
, Steve Harr, M.D.
, Mark Gilbert, M.D.
, Hyam Levitsky, M.D.
|
| http://dbpedia.org/property/location
|
Seattle, WA
|
| http://dbpedia.org/property/logo
|
File:Juno Therapeutics logo.jpg
|
| http://dbpedia.org/property/name
|
Juno Therapeutics Inc
|
| http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/Bristol-Myers_Squibb +
|
| http://dbpedia.org/property/type
|
Subsidiary
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Clade +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:2018_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:2013_establishments_in_Washington_%28state%29 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:Companies_based_in_Seattle +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Juno_Therapeutics?oldid=1122468143&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Juno_Therapeutics_logo.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.bms.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Juno_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
Juno Therapeutics Inc
|
| owl:sameAs |
http://yago-knowledge.org/resource/Juno_Therapeutics +
, http://dbpedia.org/resource/Juno_Therapeutics +
, http://www.wikidata.org/entity/Q22121867 +
, https://global.dbpedia.org/id/26KTi +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
|
| rdfs:comment |
Juno Therapeutics Inc is an American bioph … Juno Therapeutics Inc is an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO. On January 22, 2018, Juno Therapeutics was acquired by biotechnology company Celgene for $9 billion.technology company Celgene for $9 billion.
|
| rdfs:label |
Juno Therapeutics
|
